Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2008-10-15 | Dr. Ashton was the President and Chief Executive Officer of Control Delivery Systems, Inc., a drug delivery company... Dr. Ashton previously was a joint faculty member in the Departments of Ophthalmology and Surgery at the University of Kentucky, served on the faculty of Tufts University and worked as a pharmaceutical scientist at Hoffman-La-Roche. |
| 2009-10-13 | Dr. Ashton was named our President and Chief Executive Officer in January 2009... Dr. Ashton previously was a joint faculty member in the Departments of Ophthalmology and Surgery at the University of Kentucky, served on the faculty of Tufts University and worked as a pharmaceutical scientist at Hoffman-La-Roche. |
| 2010-10-25 | Dr. Ashton’s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmacology and strong knowledge of research and development uniquely position him to lead pSivida. |
| 2011-10-25 | Dr. Ashton’s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmacology and strong knowledge of research and development uniquely position him to lead pSivida in the execution of its long-term strategy. |
| 2012-10-25 | Dr. Ashton’s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmacology and strong knowledge of research and development uniquely position him to lead pSivida in the execution of its long-term strategy. |
| 2013-10-25 | Dr. Ashton’s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmaceutics and strong knowledge of research and development uniquely position him to lead pSivida in the execution of its long-term strategy. |
| 2014-10-24 | Dr. Ashton’s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmaceutics and strong knowledge of research and development uniquely position him to lead pSivida. |
| 2015-10-23 | Dr. Ashton’s long history of leadership and strategic oversight of pSivida and CDS, his role in developing and extensive knowledge of our core technology platforms, products and product candidates, his scientific expertise including his PhD in pharmaceutics and strong knowledge of research and development uniquely position him to lead pSivida. |
| 2017-05-15 | Dr. Ashton resigned as our President and Chief Executive Officer and as a member of our Board on September 14, 2016. |
| 2018-05-11 | Paul Ashton 26,781 * |
Data sourced from SEC filings. Last updated: 2026-03-05